Geron Receives Positive Opinion from the EMA Committee for Orphan Medicinal Products for Orphan Drug Designation in the European Union for Imetelstat to Treat Myelodysplastic SyndromesGlobeNewsWire • 07/01/20
Implied Volatility Surging for Geron Corporation (GERN) Stock OptionsZacks Investment Research • 06/19/20
Geron Reports Four Imetelstat Data Presentations at Virtual Edition of the European Hematology Association (EHA) Annual CongressGlobeNewsWire • 06/12/20
How Geron Corporation (GERN) Stock Stands Out in a Strong IndustryZacks Investment Research • 06/09/20
Geron Corp (GERN) CEO John Scarlett on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/29/20
Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other UpdatesGlobeNewsWire • 05/21/20
Geron Corporation (GERN) CEO John Scarlett on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/12/20